Scarica l'app Stockscreener
13.74
1.47%
-0.205
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AVTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$13.95
Aprire:
$13.79
Volume 24 ore:
239.05K
Relative Volume:
0.75
Capitalizzazione di mercato:
$181.06M
Reddito:
$1.93M
Utile/perdita netta:
$-7.96M
Rapporto P/E:
-0.00389
EPS:
-3530.8178
Flusso di cassa netto:
$-36.78M
1 W Prestazione:
-1.82%
1M Prestazione:
+29.00%
6M Prestazione:
+180.51%
1 anno Prestazione:
+44.08%
Intervallo 1D:
$13.20
$14.48
Intervallo di 1 settimana:
$13.20
$15.99
Portata 52W:
$3.39
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Nome
Avalo Therapeutics Inc
Settore
Industria
Telefono
410-522-8707
Indirizzo
1500 LIBERTY RIDGE DRIVE, WAYNE
Confronta AVTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
13.77 | 248.31M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.45 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.07 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Reiterato | H.C. Wainwright | Buy |
| 2025-09-05 | Iniziato | TD Cowen | Buy |
| 2025-08-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-02 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-25 | Iniziato | Jefferies | Buy |
| 2025-03-25 | Iniziato | Stifel | Buy |
| 2025-02-28 | Iniziato | Piper Sandler | Overweight |
| 2025-02-21 | Iniziato | Wedbush | Outperform |
| 2024-12-19 | Iniziato | BTIG Research | Buy |
| 2024-10-24 | Iniziato | H.C. Wainwright | Neutral |
| 2024-04-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Avalo Therapeutics Inc Borsa (AVTX) Ultime notizie
Real time social sentiment graph for Avalo Therapeutics Inc.Portfolio Performance Report & Pattern Based Trade Signal System - newser.com
Will Avalo Therapeutics Inc. stock keep outperforming rivalsJuly 2025 Momentum & Community Supported Trade Ideas - newser.com
Will Avalo Therapeutics Inc. stock deliver long term returns2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com
How Avalo Therapeutics Inc. (C6K0) stock responds to job market shiftsProfit Target & Fast Moving Trade Plans - newser.com
Technical analysis overview for Avalo Therapeutics Inc. stockFed Meeting & Capital Efficient Trading Techniques - newser.com
Why Avalo Therapeutics Inc. stock remains on watchlists2025 Momentum Check & Daily Stock Momentum Reports - newser.com
Multi factor analysis applied to Avalo Therapeutics Inc.Weekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com
Is it time to cut losses on Avalo Therapeutics Inc.July 2025 Snapshot & Capital Efficient Trading Techniques - newser.com
Will Avalo Therapeutics Inc. stock benefit from upcoming earnings reportsEarnings Performance Report & Daily Oversold Stock Bounce Ideas - newser.com
Avalo Therapeutics Inc. stock trend forecastMarket Movement Recap & Consistent Profit Trade Alerts - newser.com
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
How high can Avalo Therapeutics Inc. stock goJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Avalo Therapeutics, Inc. Updates Investor Presentation - TradingView
Should I buy Avalo Therapeutics Inc. (C6K0) stock before earnings season2025 Year in Review & Fast Entry and Exit Trade Plans - newser.com
How Avalo Therapeutics Inc. stock performs in weak economyRecession Risk & Smart Swing Trading Techniques - newser.com
Can Avalo Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
Will Avalo Therapeutics Inc. see short term momentumWall Street Watch & Low Risk Growth Stock Ideas - newser.com
Is Avalo Therapeutics Inc. (C6K0) stock positioned for secular growthRate Hike & Breakout Confirmation Alerts - newser.com
How moving averages guide Avalo Therapeutics Inc. trading2025 Biggest Moves & AI Driven Stock Reports - newser.com
Can Avalo Therapeutics Inc. (C6K0) stock sustain revenue momentum2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
Is Avalo Therapeutics Inc a good long term investmentRisk Mitigation Techniques & Free Superior Profit Margins - earlytimes.in
Why Avalo Therapeutics Inc. (C6K0) stock remains top rated2025 Market Outlook & AI Forecasted Entry/Exit Points - newser.com
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Sees Significant Increase in Short Interest - Defense World
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - MarketBeat
Avalo Therapeutics Strengthens Leadership with Key Appointments - The Globe and Mail
Avalo Therapeutics Expands Leadership Team with Key - GlobeNewswire
Avalo Therapeutics, Inc. Announces Board Appointments, Effective October 1, 2025 - MarketScreener
Avalo Therapeutics expands leadership with two senior appointments By Investing.com - Investing.com Canada
Avalo Therapeutics expands leadership with two senior appointments - Investing.com India
Former Longboard $2.6B Deal Architect Joins Avalo Therapeutics as CBO Ahead of Key Trial Results - Stock Titan
BTIG Research Reiterates “Buy” Rating for Avalo Therapeutics (NASDAQ:AVTX) - Defense World
Avalo Therapeutics' (AVTX) Buy Rating Reiterated at BTIG Research - MarketBeat
BTIG Reiterates Avalo Therapeutics (AVTX) Buy Recommendation - Nasdaq
BTIG Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛
What drives Avalo Therapeutics Inc stock priceSector Performance Drivers & Free Dashboard to Track Market Momentum - earlytimes.in
What analysts say about Avalo Therapeutics Inc stockBlue Chip Stock Analysis & Superior Trading Ideas - earlytimes.in
Avalo Therapeutics Inc Azioni (AVTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Avalo Therapeutics Inc Azioni (AVTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Almenoff June Sherie | Director |
Nov 12 '24 |
Buy |
12.50 |
500 |
6,250 |
500 |
1.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):